Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


Supreme Court rules on DNA patentability

High court says natural DNA cannot be patented, synthetic DNA can

In a case that has been closely watched for years, the Supreme Court put to rest an ongoing controversy over DNA patentability.

The nine justices concluded in their unanimous ruling earlier today that naturally occurring DNA—or genes from within the human body—is not patentable. However, the justices’ decision said that synthetic DNA is patentable.

The case centered on Myriad Genetics, which, according to NPR, "discovered and isolated two genes — BRCA 1 and BRCA 2 — that are highly associated with hereditary breast and ovarian cancer. Myriad patented its discovery, giving it a 20-year monopoly over use of the genes for research, diagnostics and treatment. A group of researchers, medical groups and patients sued, challenging the patent as invalid."

The case wended its way through the courts for years before landing on the high court’s docket. In an earlier appeal, the Federal Circuit found both types of DNA to be patentable.

In today’s ruling, Justice Clarence Thomas said that the lower court was wrong in the ruling.

For more InsideCounsel stories and columns on this case, see:

IP: Supreme Court hears oral argument on whether isolated DNA is a product of nature

Supreme Court hears gene patentability arguments

IP: Supreme Court will decide if human genes are patentable

Supreme Court will rule on gene patentability


Cathleen Flahardy

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.